U-Neuron Biomedical (ROCO:6973) Beginning Cash Position: NT$179.96 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6973 U-Neuron Biomedical Inc ROCO:6973
10 GF Score
Price NT$37.10
! 2 Warning Signs
View Full Analysis

What is U-Neuron Biomedical Beginning Cash Position?

U-Neuron Biomedical ROCO:6973 10 Beginning Cash Position is NT$179.96 Mil as of Dec. 2025. GuruFocus rates ROCO:6973 with a GF Score™ of 10/100. The stock has 2 warning signs investors should review.

U-Neuron Biomedical's Beginning Cash Position for the quarter that ended in Dec. 2025 was NT$179.96 Mil.

U-Neuron Biomedical's quarterly Beginning Cash Position increased from Dec. 2024 (NT$80.12 Mil) to Jun. 2025 (NT$117.80 Mil) and increased from Jun. 2025 (NT$117.80 Mil) to Dec. 2025 (NT$179.96 Mil).

U-Neuron Biomedical's annual Beginning Cash Position increased from Dec. 2023 (NT$31.02 Mil) to Dec. 2024 (NT$56.96 Mil) and increased from Dec. 2024 (NT$56.96 Mil) to Dec. 2025 (NT$117.80 Mil).

U-Neuron Biomedical Beginning Cash Position Related Terms

U-Neuron Biomedical Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for U-Neuron Biomedical's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

U-Neuron Biomedical Beginning Cash Position Chart

U-Neuron Biomedical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Beginning Cash Position
Get a 7-Day Free Trial 6.69 55.52 31.02 56.96 117.80

U-Neuron Biomedical Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Beginning Cash Position Get a 7-Day Free Trial Premium Member Only Premium Member Only 30.13 56.96 80.12 117.80 179.96
ROCO:6973
10GF Score
U-Neuron Biomedical Inc ROCO:6973
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

U-Neuron Biomedical Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of NT$179.96 Mil mean?
U-Neuron Biomedical (ROCO:6973) has a Beginning Cash Position of NT$179.96 Mil as of Dec. 2025. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on U-Neuron Biomedical and its competitors.
Is U-Neuron Biomedical's Beginning Cash Position too high?
U-Neuron Biomedical's current Beginning Cash Position is NT$179.96 Mil. Overall, U-Neuron Biomedical has a GF Score™ of 10/100, reflecting its overall financial health beyond just this single metric.
How does U-Neuron Biomedical's Beginning Cash Position compare to VRTX and REGN?
U-Neuron Biomedical's Beginning Cash Position of NT$179.96 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Biotechnology company?
A good Beginning Cash Position depends on the Biotechnology industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on U-Neuron Biomedical and its competitors. U-Neuron Biomedical's current Beginning Cash Position is NT$179.96 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is U-Neuron Biomedical stock overvalued right now?
U-Neuron Biomedical (ROCO:6973) has a current Beginning Cash Position of NT$179.96 Mil. The current Beginning Cash Position is NT$179.96 Mil. U-Neuron Biomedical's overall GF Score™ is 10/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For U-Neuron Biomedical (ROCO:6973), the current Beginning Cash Position is NT$179.96 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

U-Neuron Biomedical Business Description

Address Xintai 5th Road, 18th Floor-5, No. 99, Section. 1, Xizhi District, New Taipei City, TWN, 22175
U-Neuron Biomedical Inc is engaged in research and development of stem cell storage & separation technology, and treatment application technology. It has patent on the Technology of Culture and Isolation of Amniotic Fluid Stem Cell.
10GF Score

Get the complete analysis for ROCO:6973

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$37.10
Price